Phoenix the simple answer is yes. Brilacidin will continue to be developed in the future. How fast or how slow the process will be is the 64 thousand dollar question. I don't believe IPIX can continue as it exists today. There's too much muscle in big pharma that will be very difficult to compete with. Perhaps the BOD should lower their financial expectations and consider all reasonable proposals from the outside. What they consider reasonable probably has always been their problem.
News 
Market Data 
Discover 
AI
